Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Share-based Compensation (2019 - 2024)

SELLAS Life Sciences (SLS) has disclosed Share-based Compensation for 9 consecutive years, with $373000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Share-based Compensation fell 24.95% to $373000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $1.6 million, a 25.31% decrease, with the full-year FY2024 number at $1.6 million, down 25.31% from a year prior.
  • Share-based Compensation was $373000.0 for Q4 2024 at SELLAS Life Sciences, down from $381000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $543000.0 in Q3 2023 to a low of $141000.0 in Q4 2020.
  • A 5-year average of $348650.0 and a median of $374000.0 in 2022 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: soared 104.26% in 2021, then tumbled 35.02% in 2024.
  • SELLAS Life Sciences' Share-based Compensation stood at $141000.0 in 2020, then soared by 104.26% to $288000.0 in 2021, then surged by 54.86% to $446000.0 in 2022, then grew by 11.43% to $497000.0 in 2023, then decreased by 24.95% to $373000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLS's Share-based Compensation are $373000.0 (Q4 2024), $381000.0 (Q3 2024), and $334000.0 (Q2 2024).